Follow
Hiba Zayyad
Hiba Zayyad
Padeh Poriya Medical Center
Verified email at pmc.gov.il
Title
Cited by
Cited by
Year
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ...
The lancet Infectious diseases 18 (4), 391-400, 2018
5102018
Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial
D Yahav, E Franceschini, F Koppel, A Turjeman, T Babich, R Bitterman, ...
Clinical Infectious Diseases 69 (7), 1091-1098, 2019
3462019
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
T Brosh-Nissimov, E Orenbuch-Harroch, M Chowers, M Elbaz, L Nesher, ...
Clinical Microbiology and Infection 27 (11), 1652-1657, 2021
3242021
Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel
P Kuodi, Y Gorelik, H Zayyad, O Wertheim, KB Wiegler, K Abu Jabal, ...
npj Vaccines 7 (1), 101, 2022
1702022
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial
Y Dickstein, J Lellouche, M Ben Dalak Amar, D Schwartz, A Nutman, ...
Clinical Infectious Diseases 69 (5), 769-776, 2019
982019
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Infection 49 (5), 889-905, 2021
802021
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: In vitro synergism is not associated with better clinical outcomes
A Nutman, J Lellouche, E Temkin, G Daikos, A Skiada, ...
Clinical Microbiology and Infection 26 (9), 1185-1191, 2020
642020
Revival of old antibiotics: needs, the state of evidence and expectations
H Zayyad, N Eliakim-Raz, L Leibovici, M Paul
International journal of antimicrobial agents 49 (5), 536-541, 2017
592017
Risk factors for meningitis in neurosurgical patients with cerebrospinal fluid drains: prospective observational cohort study
K Hussein, G Rabino, O Feder, H Eghbaryeh, H Zayyad, G Sviri, ...
Acta Neurochirurgica 161, 517-524, 2019
482019
Association of receiving a fourth dose of the BNT162b vaccine with SARS-CoV-2 infection among health care workers in Israel
MJ Cohen, Y Oster, AE Moses, A Spitzer, S Benenson, A Abu-Ahmad, ...
JAMA Network Open 5 (8), e2224657-e2224657, 2022
352022
The value of open-source clinical science in pandemic response: lessons from ISARIC
A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ...
The Lancet infectious diseases 21 (12), 1623-1624, 2021
322021
ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19
M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ...
Scientific data 9 (1), 454, 2022
232022
Bacteremia Duration Study Group: Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: A noninferiority randomized controlled trial
D Yahav, E Franceschini, F Koppel, A Turjeman, T Babich, R Bitterman, ...
Clin Infect Dis 69 (7), 1091-1098, 2019
212019
Colistin resistance development following colistin-meropenem combination therapy versus colistin monotherapy in patients with infections caused by carbapenem-resistant organisms
Y Dickstein, J Lellouche, D Schwartz, A Nutman, N Rakovitsky, ...
Clinical Infectious Diseases 71 (10), 2599-2607, 2020
202020
Assessment of dry eye disease in N95 versus surgical face mask wearers during COVID-19
SH Azzam, A Nama, H Badarni, H Asael, WA Dahoud, M Mimouni, ...
Indian journal of ophthalmology 70 (3), 995-999, 2022
162022
ISARIC clinical data report issued: 14 July 2021
ISARIC Clinical Characterisation Group, JK Baillie, J Baruch, A Beane, ...
medRxiv, 2021
16*2021
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations
E Carrara, A Savoldi, LJV Piddock, F Franceschi, S Ellis, M Sharland, ...
Clinical Microbiology and Infection 28 (1), 66-72, 2022
132022
The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey
D Ben-David, A Vaturi, E Solter, E Temkin, Y Carmeli, MJ Schwaber, ...
Infection Control & Hospital Epidemiology 40 (10), 1094-1099, 2019
82019
Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance
S Frenk, E Temkin, MN Lurie-Weinberger, A Keren-Paz, R Rov, ...
Journal of Antimicrobial Chemotherapy 77 (4), 934-943, 2022
72022
Spotted fever group rickettsioses in Israel, 2010–2019
R Cohen, T Finn, F Babushkin, Y Paran, RB Ami, A Atamna, S Reisfeld, ...
Emerging Infectious Diseases 27 (8), 2117, 2021
62021
The system can't perform the operation now. Try again later.
Articles 1–20